Video
Alessio Fasano, Chair of the Congress, shares an overview of the event and the future challenges.
During IPC 2024, George Paraskevakos shared recent updates on market developments and an overview of the Biotic-related survey.
AB-Biotics recently appointed to the IPA board of directors. What opportunities and future developments? We discussed this with Miquel Bonachera.
Satish Chandran, President and Chief Executive Officer at Prodigy Biotech, Inc., details the company's program aimed at treating alcoholic liver disease, spotlighting Enterococcus faecalis as the primary antagonist.
Aran Singanayagam, research group leader at Imperial College London (UK), examined how disturbances in the airway microbiome are instrumental in the development of chronic lung diseases.
An exclusive interview with Daniel Brownell, Senior Director of Research & Development at AOBiome Therapeutics, whose core technology is ammonia oxidizing bacteria, formulated as a topical suspension of bacteria applied…
Antonio Gomes, Principal Scientist at Xbiome, talks about employing deep learning techniques to refine the prediction of natural product structures directly from gene sets.
Elran Haber, CEO at Biomica Ltd, discussed the emerging role of microbiome-based treatments in cancer care.
Johan van Hylckama Vlieg, CSO and Co-founder of Freya Biosciences, discusses the latest advancements in microbial immunotherapies for women's health.
Maria Lluch Senar, Founder and Chief Scientific Officer at Pulmobiotics SL, discusses the research on engineering Live Biotherapeutics in order to expose antigens or deliver therapeutic agents to treat complex…
